openPR Logo
Press release

Respiratory Inhaler Devices Market 2025 | Beximco Pharmaceuticals Ltd., Cipla Ltd.,

12-26-2018 11:45 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Report Insights

Respiratory Inhaler Devices Market 2025 | Beximco

Respiratory disorders such as asthma, COPD, ARDS and fibrosis result into breathing problems. Respiratory devices are used for assisting patients encountering such breathing problems. The value of global respiratory inhaler devices market is expected to reach US $43,214 million by 2025 end and it is estimated to witness 4.3% CAGR during the forecast period, 2025, according to the report by (RRI).

Global Respiratory Inhaler Devices Market Estimated to Witness 4.3% CAGR By End 2025

Major players in the global respiratory inhaler devices market are focusing on enhancement of their product portfolio by introducing cost-effective and innovative products for strengthening their market position for future advancements. These major players include Beximco Pharmaceuticals Ltd., Cipla Ltd., Koninklijke Philips N.V., PARI Medical Holding, AstraZeneca, Boehringer Ingelheim GmBH, GlaxoSmithKline plc, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., and OMRON Healthcare Europe B.V.

Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114799/Respiratory-Inhaler-Devices-Market

Combination Therapy Estimated to Gain Traction During the Forecast Period

Increasing prevalence of asthma, COPD, chronic respiratory diseases and several other respiratory diseases are driving the growth of global market for respiratory inhaler devices. Patients are inclining towards combined therapies owing to associated benefits like significant reliability in complex patients, easy reimbursement policies of therapy and increased efficacy. Combination therapies are costlier than conventional therapies. However combination therapy is likely to gain traction during the forecast period owing to increased utilization of combination therapies for COPD patients. However, a single effective inhaler for treatment of all types of respiratory diseases has not yet been discovered. This factor is restraining the growth of global respiratory inhaler devices market. Other impeding factors include drug-related complications and side effects, lack of skilled physicians, nurses & pulmonologists, unawareness and high costs of inhaler devices.

COPD Segment Expected to Witness 4.8% CAGR During 2015 to 2025

Based on disease indication, the market is categorised into asthma, pulmonary arterial hypertension, COPD and other respiratory diseases. COPD is estimated to be the third largest cause of death and fifth largest cause of disability during 2015 to 2020. Several heath programs conducted around the world are expected to result into COPD segment. This segment is anticipated to witness 4.8% CAGR during the forecast period.

Request Report Discount: https://www.researchreportinsights.com/report/discount/110114799/Respiratory-Inhaler-Devices-Market

Application of Bluetooth and GPS Fuelling Demand for Digitally Operated Inhalers

Based on technology, the market is bifurcated into manually operated and digitally operated inhaler devices. Application of Bluetooth and GPS in inhaler devices is anticipated to fuel demand for digitally operated inhaler devices during the forecast period. This segment is estimated to witness 3.8% CAGR during 2015 to 2025.

Metered Dose Inhaler Segment Estimated to Remain Dominant During the Forecast Period

Based on product type, the market is categorised into metered dose inhaler, dry powder inhaler and nebuliser. Metered dose inhaler accounted for more than 69.9% share of global market for respiratory inhaler devices in 2015 and this segment is estimated to remain dominant during the forecast period.

APEJ Estimated to Witness Fastest Growth During 2015 to 2025

Region-wise, the market is categorised into North America, Western Europe, Eastern Europe, Middle East & Africa (MEA), Latin America and Asia Pacific Excluding Japan (APEJ) and Japan. North America dominated the overall market with 40% share in 2015. And, Asia Pacific Excluding Japan is estimated to witness fastest growth with 5% CAGR during 2015 to 2025. Nebuliser is estimated to reflect 3.8% CAGR by value in North America, Europe and Asia Pacific during the forecast period.

Report Analysis: https://www.researchreportinsights.com/report/rd/110114799/Respiratory-Inhaler-Devices-Market

About Us:
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends.

Contact Us:
Research Report Insights (RRI)
42 Joseph Street
Port carling P0B 1J0
Muskoka, Ontario1
Phone - +1-631-721-4201
Website: https://www.researchreportinsights.com/
Email: sales@researchreportinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Inhaler Devices Market 2025 | Beximco Pharmaceuticals Ltd., Cipla Ltd., here

News-ID: 1460200 • Views:

More Releases from Research Report Insights

Automotive Brake System Market 5.7% of CAGR throughout 2017-2022 Research Report Insights
Automotive Brake System Market 5.7% of CAGR throughout 2017-2022 Research Report …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Automotive Brake System Market 2022 | Continental AG, Robert Bosch GmbH, Wabco Holdings, Inc., ZF Friedrichshafen AG, Aisin Seiki Co, Ltd., Knorr-Bremse AG, Akebono Brake Industry Co. Ltd
Automotive Brake System Market 2022 | Continental AG, Robert Bosch GmbH, Wabco H …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Tarpaulin Sheets Market These factors, thus, are likely to boost the plastic mar …
A tarpaulin is a big sheet of water-proof material available in various sizes, generally being crafted from plastic like HDPE, LDPE. Tarps can be used to refuge any kind of items. Tarpaulins can efficiently be used to cover goods in the course of shipping and then they also can be used to house goods internal of a truck body so they are not uncovered to the elements. The Tarpaulin Sheets Market
Research Report Insights present kayaks market by 21 percent, or over by $42 mil …
Kayaking is a watersport which involves paddling using a double-bladed oar and a small boat known as a kayak. The boats come in a variety of sizes and types, depending on their intended use, but most kayaks feature an enclosed deck which covers the legs. The boat sits low in the water & usually only accommodates the single paddler, but tandem kayaks hold two people and some boats hold three

All 5 Releases


More Releases for Respiratory

Global Respiratory Devices and Equipment (Therapeutic) Market | Global Respirato …
The respiratory devices & equipment therapeutic market comprises of the sales of respiratory devices & equipment used for treating the patients with acute or chronic respiratory disorders for instance chronic obstructive pulmonary disease (COPD), sleep disorders, chronic bronchitis, asthma, etc. The market includes sales of respiratory monitoring devices establishments mainly engaged in the manufacturing of oxygen concentrators, nebulizers, humidifiers, positive airway pressure devices, ventilators, capnographs, and gas analyzers. According to study,
Global Respiratory Monitoring Devices Market | Global Respiratory Monitoring Dev …
Respiration is a unique process of human lives, which jumps at the time of birth and lasts till decease. A healthy human body is skilled of respiration process for numerous years but, due to rising levels of pollution in urban cities and lives concerning tobacco smoking, clogging of airways and other structures of the lung is turning into a common concern across the globe. The respiratory monitoring devices market comprises
Middle East and Africa Respiratory InhalerMarket- AstraZeneca is advancing clini …
Recent Developments AstraZeneca is multinational pharmaceutical and Biopharmaceutical Company. The company provides innovative medicines which are used by millions of people worldwide. AstraZeneca reduces the risk of death and disease progression. The company primarily focuses on development and discovery of cardiovascular, respiratory and inflammation, oncology and infectious disease. To know more:https://www.marketdataforecast.com/market-reports/middle-east-and-africa-respiratory-inhaler-market-6377/ Market Segmentations: Market Data Forecast published a report named Middle East and Africa Respiratory InhalerMarket. It is estimated to grow at a robust
Respiratory Devices Analysis Report of Respiratory Devices in Global Market 2018 …
- Global Respiratory Devices Market: Overview Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, respiratory devices are used to deliver medicines to treat several respiratory diseases. Moreover, these devices are used to diagnose respiratory problems in patients. Increase in incidence of COPD and sleep apnea, strategic alliance between key players, and rise in government expenditure are the major factors projected to propel the
Neonatal Respiratory Distress Syndrome Market is driven by high prevalence of re …
Neonatal respiratory distress syndrome, also referred to as infant respiratory distress syndrome is characterized by a particular condition often observed in premature babies, usually born about six weeks before their due dates. During this condition, lungs of the premature infants lose the ability to produce enough surfactants in order to provide oxygen to the body. Surfactants are liquids made up of fat and proteins and it helps the lungs to
Global Respiratory Monitoring Devices Market to Benefit from Increasing Prevalen …
Respiratory disease is a serious public health concern due to rapidly growing number of smokers worldwide. Governments are implementing various health schemes to reduce the death rate caused due to respiratory disease and disorders. Respiratory disease is a medical condition that affects the structure and organs (respiratory system) associated with respiration or breathing. Rise in respiratory diseases such as chronic obstructive pulmonary diseases, asthma, and lung cancer has triggered the growth